Skip to main content
Clinical Trials/NCT04229251
NCT04229251
Unknown
Not Applicable

Efficacy of Online Mindfulness-Based Intervention on Emerging Malaysian Chinese Adults With Attention Deficit/Hyperactivity Disorder: A Randomized Controlled Trial

Universiti Tunku Abdul Rahman1 site in 1 country108 target enrollmentOctober 15, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Attention-deficit Hyperactivity Disorder
Sponsor
Universiti Tunku Abdul Rahman
Enrollment
108
Locations
1
Primary Endpoint
Change from pretest Hyperactivity-Impulsivity scores at 1-month follow-up.
Last Updated
5 years ago

Overview

Brief Summary

This study aims to evaluate the efficacies of an online mindfulness-based intervention for emerging adults with ADHD in Malaysia. The investigators hypothesized that online mindfulness-based intervention may improve ADHD symptoms and executive functions of emerging adults with ADHD.

Detailed Description

Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder that often persist to adulthood. In Malaysia, the Chinese ethnic is having the highest prevalence rate of hyperactivity symptoms. Nevertheless, there are only limited evidence-based treatment options targeting the core symptoms of ADHD, as well as executive functions in adulthood. In addition, conventional psychotherapeutic approaches for adults with ADHD have found to be highly labor-intensive. Emerging adulthood is a distinct developmental stage of 18 - 29 years old, with unique challenges that rarely addressed in mental health system. Recently, mindfulness-based intervention appears to be a promising treatment for adults living with ADHD but it has not been evaluated among Malaysian emerging adults with ADHD. The investigators proposed a two-arm randomized controlled trial, comparing an eight-week online mindfulness-based intervention program with an online introductory psychology program. The outcomes include changes of inattention symptom, changes of hyperactivity-impulsivity symptom, and changes of executive functions from pretest to posttest, 1-month follow-up and 3-month follow-up. To investigators' best knowledge, this randomized controlled trial will be the first to test the efficacious of online mindfulness-based intervention for ADHD among emerging adults. It will provide evidence on the efficacious of online treatment for this often-overlooked population in the mental healthcare system.

Registry
clinicaltrials.gov
Start Date
October 15, 2020
End Date
December 30, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Pheh Kai Shuen

Lecturer

Universiti Tunku Abdul Rahman

Eligibility Criteria

Inclusion Criteria

  • 18 to 29 years old.
  • Diagnosis of ADHD.
  • Completed at least six years of Chinese education.
  • Participants taking psychotropic prescriptions will be allowed to participate, if they prescriptions were stable for at least 6 weeks prior to their participation in this study.

Exclusion Criteria

  • History or current presence of substance dependence, psychotic illness, bipolar disorder, personality disorders, conduct disorder, chronic suicidal, or self-injurious behaviour as reported in the Diagnostic Interview For Anxiety, Mood, Obsessive-Compulsive and Related Neuropsychiatric Disorders (DIAMOND).
  • Non-verbal intellectual ability of percentile ranks 25 or below.
  • Received cognitive-behavioural therapy (CBT) for ADHD or any form of mindfulness-based intervention in the past 2 years.

Outcomes

Primary Outcomes

Change from pretest Hyperactivity-Impulsivity scores at 1-month follow-up.

Time Frame: 12 weeks

The ADHD Self-Report Scale (Hyperactivity-Impulsivity Subscale) is used in monitoring treatment response of Adult ADHD. The Hyperactivity-Impulsivity subscale scores range from 0 to 36, where higher scores indicate more severe levels of hyperactivity-impulsivity.

Change from pretest Executive Function Deficits scores at posttest.

Time Frame: 8 weeks

The Adult Executive Functioning Inventory (ADEXI) is used in monitoring treatment response of Adult ADHD. The Executive Function Deficits subscale scores range from 14 to 70, where higher scores indicate more severe levels of executive function deficits.

Change from pretest Inattention scores at 1-month follow-up.

Time Frame: 12 weeks

The ADHD Self-Report Scale (Inattention Subscale) is used in monitoring treatment response of Adult ADHD. The Inattention subscale scores range from 0 to 36, where higher scores indicate more severe levels of inattention.

Change from pretest Hyperactivity-Impulsivity scores at 3-month follow-up.

Time Frame: 20 weeks

The ADHD Self-Report Scale (Hyperactivity-Impulsivity Subscale) is used in monitoring treatment response of Adult ADHD. The Hyperactivity-Impulsivity subscale scores range from 0 to 36, where higher scores indicate more severe levels of hyperactivity-impulsivity.

Change from baseline Inattention scores at 3-month follow-up

Time Frame: 20 weeks

The ADHD Self-Report Scale (Inattention Subscale) is used in monitoring treatment response of Adult ADHD. The Inattention subscale scores range from 0 to 36, where higher scores indicate more severe levels of inattention.

Change from pretest Hyperactivity-Impulsivity scores at posttest.

Time Frame: 8 weeks

The ADHD Self-Report Scale (Hyperactivity-Impulsivity Subscale) is used in monitoring treatment response of Adult ADHD. The Hyperactivity-Impulsivity subscale scores range from 0 to 36, where higher scores indicate more severe levels of hyperactivity-impulsivity.

Change from pretest Executive Function Deficits scores at 3-month follow-up.

Time Frame: 20 weeks

The Adult Executive Functioning Inventory (ADEXI) is used in monitoring treatment response of Adult ADHD. The Executive Function Deficits subscale scores range from 14 to 70, where higher scores indicate more severe levels of executive function deficits.

Change from pretest Inattention scores at posttest.

Time Frame: 8 weeks

The ADHD Self-Report Scale (Inattention Subscale) is used in monitoring treatment response of Adult ADHD. The Inattention subscale scores range from 0 to 36, where higher scores indicate more severe levels of inattention.

Change from pretest Executive Function Deficits scores at 1-month follow-up.

Time Frame: 12 weeks

The Adult Executive Functioning Inventory (ADEXI) is used in monitoring treatment response of Adult ADHD. The Executive Function Deficits subscale scores range from 14 to 70, where higher scores indicate more severe levels of executive function deficits.

Study Sites (1)

Loading locations...

Similar Trials